Clinical Trial Update: Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oral vancomycin to prevent Clostridium difficile infections in patients undergoing allogeneic hematopoietic stem cell transplantation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection
• Stem Cell Transplant Complications

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Clostridium Difficile Infections, Stem Cell Transplant Complications | Phase 3 | Status: UNKNOWN